Marc Hertz, Co Founder & CEO of GRI Bio (NASDAQ:GRI) presented at Benzinga’s webinar: Pharma Companies Vs. A Tough Macro Backdrop.
The event brought together leaders from the pharmaceutical and biotech industries to discuss the prevailing economic headwinds and how to find success in such an environment.
Mr. Hertz shared his deep knowledge of the industry, the macro picture, and spoke about the science behind his company's therapies, specifically how T Cells help the body heal itself.
Watch his presentation here:
Want to get involved in one of our events? Learn more here.
Featured photo by Pawel Czerwinski on Unsplash
This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
